71 related articles for article (PubMed ID: 16837630)
21. Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.
Mills AA
Nat Rev Cancer; 2010 Oct; 10(10):669-82. PubMed ID: 20865010
[TBL] [Abstract][Full Text] [Related]
22. PTEN inhibits BMI1 function independently of its phosphatase activity.
Fan C; He L; Kapoor A; Rybak AP; De Melo J; Cutz JC; Tang D
Mol Cancer; 2009 Nov; 8():98. PubMed ID: 19903340
[TBL] [Abstract][Full Text] [Related]
23. BMI-1 expression is inversely correlated with the grading of renal clear cell carcinoma.
Kozakowski N; Soleiman A; Pammer J
Pathol Oncol Res; 2008 Mar; 14(1):9-13. PubMed ID: 18347933
[TBL] [Abstract][Full Text] [Related]
24. Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma.
Wang H; Pan K; Zhang HK; Weng DS; Zhou J; Li JJ; Huang W; Song HF; Chen MS; Xia JC
J Cancer Res Clin Oncol; 2008 May; 134(5):535-41. PubMed ID: 17917742
[TBL] [Abstract][Full Text] [Related]
25. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients.
Silva J; García V; García JM; Peña C; Domínguez G; Díaz R; Lorenzo Y; Hurtado A; Sánchez A; Bonilla F
Breast Cancer Res; 2007; 9(4):R55. PubMed ID: 17711569
[TBL] [Abstract][Full Text] [Related]
26. Bmi1, stem cells, and senescence regulation.
Park IK; Morrison SJ; Clarke MF
J Clin Invest; 2004 Jan; 113(2):175-9. PubMed ID: 14722607
[TBL] [Abstract][Full Text] [Related]
27. Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL.
van Galen JC; Muris JJ; Oudejans JJ; Vos W; Giroth CP; Ossenkoppele GJ; Otte AP; Raaphorst FM; Meijer CJ
J Clin Pathol; 2007 Feb; 60(2):167-72. PubMed ID: 16837630
[TBL] [Abstract][Full Text] [Related]
28. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
Silva J; García JM; Peña C; García V; Domínguez G; Suárez D; Camacho FI; Espinosa R; Provencio M; España P; Bonilla F
Clin Cancer Res; 2006 Dec; 12(23):6929-36. PubMed ID: 17145810
[TBL] [Abstract][Full Text] [Related]
29. BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer.
Zhang XW; Sheng YP; Li Q; Qin W; Lu YW; Cheng YF; Liu BY; Zhang FC; Li J; Dimri GP; Guo WJ
Mol Cancer; 2010 Feb; 9():40. PubMed ID: 20170541
[TBL] [Abstract][Full Text] [Related]
30. Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression.
Fan C; He L; Kapoor A; Gillis A; Rybak AP; Cutz JC; Tang D
Biochim Biophys Acta; 2008 Nov; 1782(11):642-8. PubMed ID: 18817867
[TBL] [Abstract][Full Text] [Related]
31. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
Muris JJ; Meijer CJ; Vos W; van Krieken JH; Jiwa NM; Ossenkoppele GJ; Oudejans JJ
J Pathol; 2006 Apr; 208(5):714-23. PubMed ID: 16400625
[TBL] [Abstract][Full Text] [Related]
33. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.
Glinsky GV; Berezovska O; Glinskii AB
J Clin Invest; 2005 Jun; 115(6):1503-21. PubMed ID: 15931389
[TBL] [Abstract][Full Text] [Related]
34. Of mice, flies, and man: the emerging role of polycomb-group genes in human malignant lymphomas.
Raaphorst FM
Int J Hematol; 2005 May; 81(4):281-7. PubMed ID: 15914355
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]